Report cover image

Global Multi-target MET TKIs Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 197 Pages
SKU # APRC20277502

Description

Summary

According to APO Research, The global Multi-target MET TKIs market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Multi-target MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Multi-target MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Multi-target MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Multi-target MET TKIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Multi-target MET TKIs include BDR Pharma, Beacon Pharmaceuticals, Drug International, Elemento Pharma, Everest Pharmaceuticals, Exelixis, Genvio Pharma, MSN Labs and Zydus, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Multi-target MET TKIs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Multi-target MET TKIs, also provides the sales of main regions and countries. Of the upcoming market potential for Multi-target MET TKIs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Multi-target MET TKIs sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Multi-target MET TKIs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Multi-target MET TKIs sales, projected growth trends, production technology, application and end-user industry.

Multi-target MET TKIs Segment by Company

BDR Pharma
Beacon Pharmaceuticals
Drug International
Elemento Pharma
Everest Pharmaceuticals
Exelixis
Genvio Pharma
MSN Labs
Zydus
Pfizer
Stada Arzneimittel
Teva
万邦医药
Cipla
Multi-target MET TKIs Segment by Type

Crizotinib
cabozantinib
Other
Multi-target MET TKIs Segment by Application

Medullary Thyroid Cancer
Non-small Cell Lung Cancer
Other
Multi-target MET TKIs Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multi-target MET TKIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Multi-target MET TKIs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multi-target MET TKIs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Multi-target MET TKIs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi-target MET TKIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multi-target MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Multi-target MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Multi-target MET TKIs Market Size, 2020 VS 2024 VS 2031
1.3 Global Multi-target MET TKIs Market Size Estimates and Forecasts (2020-2031)
1.4 Global Multi-target MET TKIs Sales Estimates and Forecasts (2020-2031)
1.5 Global Multi-target MET TKIs Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Multi-target MET TKIs Market Dynamics
2.1 Multi-target MET TKIs Industry Trends
2.2 Multi-target MET TKIs Industry Drivers
2.3 Multi-target MET TKIs Industry Opportunities and Challenges
2.4 Multi-target MET TKIs Industry Restraints
3 Multi-target MET TKIs Market by Manufacturers
3.1 Global Multi-target MET TKIs Revenue by Manufacturers (2020-2025)
3.2 Global Multi-target MET TKIs Sales by Manufacturers (2020-2025)
3.3 Global Multi-target MET TKIs Average Sales Price by Manufacturers (2020-2025)
3.4 Global Multi-target MET TKIs Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Multi-target MET TKIs Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Multi-target MET TKIs Manufacturers, Product Type & Application
3.7 Global Multi-target MET TKIs Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Multi-target MET TKIs Market CR5 and HHI
3.8.2 Global Top 5 and 10 Multi-target MET TKIs Players Market Share by Revenue in 2024
3.8.3 2024 Multi-target MET TKIs Tier 1, Tier 2, and Tier 3
4 Multi-target MET TKIs Market by Type
4.1 Multi-target MET TKIs Type Introduction
4.1.1 Crizotinib
4.1.2 cabozantinib
4.1.3 Other
4.2 Global Multi-target MET TKIs Sales by Type
4.2.1 Global Multi-target MET TKIs Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Multi-target MET TKIs Sales by Type (2020-2031)
4.2.3 Global Multi-target MET TKIs Sales Market Share by Type (2020-2031)
4.3 Global Multi-target MET TKIs Revenue by Type
4.3.1 Global Multi-target MET TKIs Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Multi-target MET TKIs Revenue by Type (2020-2031)
4.3.3 Global Multi-target MET TKIs Revenue Market Share by Type (2020-2031)
5 Multi-target MET TKIs Market by Application
5.1 Multi-target MET TKIs Application Introduction
5.1.1 Medullary Thyroid Cancer
5.1.2 Non-small Cell Lung Cancer
5.1.3 Other
5.2 Global Multi-target MET TKIs Sales by Application
5.2.1 Global Multi-target MET TKIs Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Multi-target MET TKIs Sales by Application (2020-2031)
5.2.3 Global Multi-target MET TKIs Sales Market Share by Application (2020-2031)
5.3 Global Multi-target MET TKIs Revenue by Application
5.3.1 Global Multi-target MET TKIs Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Multi-target MET TKIs Revenue by Application (2020-2031)
5.3.3 Global Multi-target MET TKIs Revenue Market Share by Application (2020-2031)
6 Global Multi-target MET TKIs Sales by Region
6.1 Global Multi-target MET TKIs Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Multi-target MET TKIs Sales by Region (2020-2031)
6.2.1 Global Multi-target MET TKIs Sales by Region (2020-2025)
6.2.2 Global Multi-target MET TKIs Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Multi-target MET TKIs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Multi-target MET TKIs Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Multi-target MET TKIs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Multi-target MET TKIs Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Multi-target MET TKIs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Multi-target MET TKIs Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Multi-target MET TKIs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Multi-target MET TKIs Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Multi-target MET TKIs Revenue by Region
7.1 Global Multi-target MET TKIs Revenue by Region
7.1.1 Global Multi-target MET TKIs Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Multi-target MET TKIs Revenue by Region (2020-2025)
7.1.3 Global Multi-target MET TKIs Revenue by Region (2026-2031)
7.1.4 Global Multi-target MET TKIs Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Multi-target MET TKIs Revenue (2020-2031)
7.2.2 North America Multi-target MET TKIs Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Multi-target MET TKIs Revenue (2020-2031)
7.3.2 Europe Multi-target MET TKIs Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Multi-target MET TKIs Revenue (2020-2031)
7.4.2 Asia-Pacific Multi-target MET TKIs Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Multi-target MET TKIs Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Multi-target MET TKIs Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 BDR Pharma
8.1.1 BDR Pharma Comapny Information
8.1.2 BDR Pharma Business Overview
8.1.3 BDR Pharma Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 BDR Pharma Multi-target MET TKIs Product Portfolio
8.1.5 BDR Pharma Recent Developments
8.2 Beacon Pharmaceuticals
8.2.1 Beacon Pharmaceuticals Comapny Information
8.2.2 Beacon Pharmaceuticals Business Overview
8.2.3 Beacon Pharmaceuticals Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Beacon Pharmaceuticals Multi-target MET TKIs Product Portfolio
8.2.5 Beacon Pharmaceuticals Recent Developments
8.3 Drug International
8.3.1 Drug International Comapny Information
8.3.2 Drug International Business Overview
8.3.3 Drug International Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Drug International Multi-target MET TKIs Product Portfolio
8.3.5 Drug International Recent Developments
8.4 Elemento Pharma
8.4.1 Elemento Pharma Comapny Information
8.4.2 Elemento Pharma Business Overview
8.4.3 Elemento Pharma Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Elemento Pharma Multi-target MET TKIs Product Portfolio
8.4.5 Elemento Pharma Recent Developments
8.5 Everest Pharmaceuticals
8.5.1 Everest Pharmaceuticals Comapny Information
8.5.2 Everest Pharmaceuticals Business Overview
8.5.3 Everest Pharmaceuticals Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Everest Pharmaceuticals Multi-target MET TKIs Product Portfolio
8.5.5 Everest Pharmaceuticals Recent Developments
8.6 Exelixis
8.6.1 Exelixis Comapny Information
8.6.2 Exelixis Business Overview
8.6.3 Exelixis Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Exelixis Multi-target MET TKIs Product Portfolio
8.6.5 Exelixis Recent Developments
8.7 Genvio Pharma
8.7.1 Genvio Pharma Comapny Information
8.7.2 Genvio Pharma Business Overview
8.7.3 Genvio Pharma Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Genvio Pharma Multi-target MET TKIs Product Portfolio
8.7.5 Genvio Pharma Recent Developments
8.8 MSN Labs
8.8.1 MSN Labs Comapny Information
8.8.2 MSN Labs Business Overview
8.8.3 MSN Labs Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 MSN Labs Multi-target MET TKIs Product Portfolio
8.8.5 MSN Labs Recent Developments
8.9 Zydus
8.9.1 Zydus Comapny Information
8.9.2 Zydus Business Overview
8.9.3 Zydus Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Zydus Multi-target MET TKIs Product Portfolio
8.9.5 Zydus Recent Developments
8.10 Pfizer
8.10.1 Pfizer Comapny Information
8.10.2 Pfizer Business Overview
8.10.3 Pfizer Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Pfizer Multi-target MET TKIs Product Portfolio
8.10.5 Pfizer Recent Developments
8.11 Stada Arzneimittel
8.11.1 Stada Arzneimittel Comapny Information
8.11.2 Stada Arzneimittel Business Overview
8.11.3 Stada Arzneimittel Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Stada Arzneimittel Multi-target MET TKIs Product Portfolio
8.11.5 Stada Arzneimittel Recent Developments
8.12 Teva
8.12.1 Teva Comapny Information
8.12.2 Teva Business Overview
8.12.3 Teva Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Teva Multi-target MET TKIs Product Portfolio
8.12.5 Teva Recent Developments
8.13 万邦医药
8.13.1 万邦医药 Comapny Information
8.13.2 万邦医药 Business Overview
8.13.3 万邦医药 Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 万邦医药 Multi-target MET TKIs Product Portfolio
8.13.5 万邦医药 Recent Developments
8.14 Cipla
8.14.1 Cipla Comapny Information
8.14.2 Cipla Business Overview
8.14.3 Cipla Multi-target MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Cipla Multi-target MET TKIs Product Portfolio
8.14.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Multi-target MET TKIs Value Chain Analysis
9.1.1 Multi-target MET TKIs Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Multi-target MET TKIs Production Mode & Process
9.2 Multi-target MET TKIs Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Multi-target MET TKIs Distributors
9.2.3 Multi-target MET TKIs Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.